The University of Florida Genetics Institute will host its ninth annual symposium, Florida Genetics 2013, October 9-10, at the Cancer/Genetics Research Complex. The program will include distinguished guest speakers and UF faculty presenting on important topics of contemporary genetics research, as well as two poster sessions, a reception, and an art exhibition – CODIFIED III Art + Genetics.
Registration, Abstract Submission, and the Program will be available here mid-August, 2013.
Sessions and speakers include:
Translation of Discovery
- William E. Evans, PharmD (keynote), Director and CEO, St. Jude Children’s Research Hospital
- Elaine A. Ostrander, PhD, Chief and NIH Distinguished Investigator, Cancer Genetics Branch, NIH
- Gary F. Peter, PhD, Professor, Forest Resources and Conservation, University of Florida
- Gerard Karsenty, MD, PhD, Professor and Chair, Genetics and Development, Columbia University Medical Center
- Arthur S. Edison, PhD, Professor, Biochemistry and Molecular Biology, University of Florida
- Clint Chapple, PhD, Distinguished Professor of Biochemistry, Purdue University
- Alisa Huffaker, PhD, Research Molecular Biologist, Agricultural Research Service, USDA (invited)
- Michael Lynch, PhD, Distinguished Professor of Biology, Indiana University
- Michael M. Miyamoto, PhD, Professor, Biology, University of Florida
- Gunter P. Wagner, PhD, Alison Richard Professor of Ecology and Evolutionary Biology, Yale University
- Stuart F. McDaniel, PhD, Assistant Professor, Biology, University of Florida
Dr. Evans is Director and Chief Executive Officer of St. Jude Children’s Research Hospital (SJCRH), and is a Professor of Pediatrics & Pharmacy at the University of Tennessee Colleges of Medicine and Pharmacy.
For the past 36 years, his research has focused on the pharmacogenomics of anticancer agents in children, for which he has received three consecutive NIH MERIT Awards from the National Cancer Institute (1987-2015).
He has authored over 300 articles and numerous book chapters, has received several national awards for his research, and is recognized by ISI as a “Highly Cited Scientist” in pharmacology.
Dr. Evans has served as CEO of SJCRH since 2004, during which time St. Jude has been ranked annually in the top 10 best places to work in academia, ranked #1 children’s cancer hospital by Parents Magazine (2009) and US News and World Report (2010), and listed by Fortune magazine among the top 100 companies to work for in the US (each year since 2011).
FG2013 is sponsored by the University of Florida Genetics Institute and a number of other University of Florida partners, including:
- Department of Molecular Genetics and Microbiology, College of Medicine
- Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine
- Interdisciplinary Center for Biotechnology Research
- Center for Epigenetics, College of Medicine
- Center for Pharmacogenomics, College of Pharmacy
- Clinical and Translational Science Institute
- College of Liberal Arts and Sciences
- Florida Agricultural Experiment Station
- Animal Molecular & Cellular Biology Graduate Program
- Plant Molecular & Cellular Biology Graduate Program
We look forward to welcoming you in October to FG2013!